Finance

Lists
Why is MRVI down 2.92%?
Dive Deeper
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
$ 6.98
-2.92%
(-0.21) 1D
$ 6.98
0.00% (0.00)
After hours
Closed: 11-р сарын 20, 16:00:02 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
$ 7.06
High
$ 7.17
Low
$ 6.91
Mkt. cap
1.81 тэрбум
Avg. vol.
2.22 сая
Volume
1.79 сая
52-wk high
$ 9.42
52-wk low
$ 2.80
EPS
-$ 0.45
Beta
0.61
Shares outstanding
149.25 сая
No. of employees
410
Open
$ 7.06
High
$ 7.17
Low
$ 6.91
Mkt. cap
1.81 тэрбум
Avg. vol.
2.22 сая
Volume
1.79 сая
52-wk high
$ 9.42
52-wk low
$ 2.80
EPS
-$ 0.45
Beta
0.61
Shares outstanding
149.25 сая
No. of employees
410
News stories
From web sources and news partners
About Maravai Lifesciences Holdings Inc
CEO-
Employees410
Founded2014
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 5 analysts giving stock ratings to MRVI in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current $ 6.98
$ 11.00 (+57.59%)
Average
$ 9.50 (+36.10%)
Lowest
$ 8.00 (+14.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Knight
KeyBanc
Buy
Upgraded
$ 11.00
+57.6%
11/11/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
$ 10.00
+43.3%
11/05/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$ 9.50
+36.1%
11/05/2026
Brendan Smith
TD Cowen
Buy
Initiated
$ 9.00
+28.9%
10/05/2026
Unknown Analyst
UBS
Hold
Initiated
$ 8.00
+14.6%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
$ 8.00
+14.6%
09/09/2026
Evan Stampler
Wells Fargo
Buy
Maintained
$ 6.50
-6.9%
08/07/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$ 6.50
-6.9%
08/07/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
08/07/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
05/11/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
$ 6.00
-14%
05/08/2026
Catherine Ramsey Schulte
Robert W. Baird
Hold
Maintained
$ 3.00
-57%
02/26/2026
Unknown Analyst
Jefferies
Buy
Reiterated
$ 5.00
-28.4%
02/26/2026
Last report
2026 оны 11-р сарын 5
Fiscal period
Q3 2026
-$ 0.03 / -$ 0.06
+46.28%beat
Revenue / Est. (USD)
45.85 сая / 43.53 сая
+5.34%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
49.87 сая
65.84 сая
51.44 сая
45.85 сая
Cost of goods sold
35.32 сая
32.14 сая
30.79 сая
29.66 сая
Cost of revenue
35.32 сая
32.14 сая
30.79 сая
29.66 сая
Research and development expenses
3.79 сая
3.89 сая
3.70 сая
3.39 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.38 сая
29.09 сая
32.07 сая
30.50 сая
Operating expense
34.17 сая
32.98 сая
35.77 сая
33.89 сая
Total operating expenses
69.50 сая
65.12 сая
66.56 сая
63.55 сая
Operating income
-19.63 сая
720.00 мян
-15.12 сая
-17.70 сая
Other non operating income
-43.00 мян
-494.00 мян
-52.00 мян
-27.00 мян
EBT including unusual items
-63.01 сая
-6.53 сая
-21.80 сая
-24.08 сая
EBT excluding unusual items
-23.84 сая
-3.65 сая
-18.82 сая
-21.16 сая
Income tax expense
6.00 мян
-151.00 мян
-171.00 мян
-75.00 мян
Effective tax rate
-0.01%
2.31%
0.78%
0.31%
Other operating expenses
-
-
-
-
Net income
-35.68 сая
-3.73 сая
-12.42 сая
-13.84 сая
Net profit margin
-71.55%
-5.67%
-24.14%
-30.18%
Earnings per share
-0.04
0.01
-0.02
-0.03
Interest and investment income
2.38 сая
1.87 сая
1.16 сая
598.00 мян
Interest expense
-6.56 сая
-5.75 сая
-4.81 сая
-4.03 сая
Net interest expenses
-4.17 сая
-3.88 сая
-3.65 сая
-3.43 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.18 сая
12.09 сая
-3.34 сая
-5.50 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс